Prof Amrith Rao (@urorao) profile picture

Robotic Urological Surgeon with Special Interest in Urologic Cancers

Joined January 2012
Photo by Prof Amrith Rao (@urorao)Photo by Prof Amrith Rao (@urorao)Photo by Prof Amrith Rao (@urorao)Photo by Prof Amrith Rao (@urorao)Photo by Prof Amrith Rao (@urorao)Photo by Prof Amrith Rao (@urorao)Photo by Prof Amrith Rao (@urorao)Photo by Prof Amrith Rao (@urorao)Photo by Prof Amrith Rao (@urorao)Photo by Prof Amrith Rao (@urorao)
Exciting times ahead for prostate cancer!
#ESMO26 Personalized Systemic Therapy for mHSPC @AOmlin @urotoday Select ongoing Phase III trials in mHSPC likely to read-out in the next ~1-5 yrs 👇
1
4
220
Prof Amrith Rao retweeted
#ESMO26 Personalized Systemic Therapy for mHSPC @AOmlin @urotoday Two Practice Decision Frameworks: 🔔High volume mHSPC in fit pts 🔔Low volume mHSPC in fit pts
46
1
75
4,333
Interesting!
I left @Apple to build healthcare that listens and acts early. Today, I'm excited to introduce UniqueHuman. We're building proactive healthcare agents that handle every step of care for people with chronic conditions. Our mission is to end chronic suffering. Today, we begin with migraines.
86
Replying to @canarabank
@canarabank Dear Canara Bank! It’s extremely dissatisfying that almost every month we need to re-register on the app! Can’t that be permanently fixed?! Either all the banking apps in the world are wrong or you are not doing something right!
3
106
Dear Team Again I have been logged out with the App asking me to log in again. Highly disappointing. no other Indian or foreign bank do this @canarabank @CBOFofficial @nsitharaman @nsitharamanoffc @RBI
3
66
Every time you log on, you need to enter a new MPIN AND PIN! Cannot be doing every month! Pls fix it! @canarabank @TNMANOHARAN
15
⭐ Top 5 advances in renal cell carcinoma that shaped clinical practice in 2025 From adjuvant immunotherapy to updated guidelines and key translational insights, these advances are reshaping how we treat RCC, with a direct impact on clinical decision-making and patient selection. 🔬 Evidence 🧬 Biology ⚖️ Clinical practice 👉 Full article ⬇️ nitter.cf/nataliagandur/status/2… Insights relevant for daily practice in RCC. @DrChoueiri @BrianRini @neerajaiims @tompowles1 @PGrivasMDPhD @montypal @JCO_ASCO @OncoAlert @Uromigos @MedicalwatchHQ
1
35
1
87
6,259
Localised prostate cancer just changed. Again. ESMO 2026 brings clarity on who to observe, who to escalate, and which trials actually matter 👇 🧠 Diagnosis MRI before biopsy is standard High-resolution US is a valid alternative (RCT n=678) 🧭 Low risk Active surveillance is safe ProtecT 15-yr data shows similar survival vs RP/RT ☢️ Radiotherapy Shorter is better CHHiP ➜ moderate hypofractionation HYPO-RT-PC ➜ ultra-hypofractionation PACE-B ➜ SBRT works in selected IR disease 📈 High risk RT + long-term ADT saves lives SPCG-7 | NCIC/MRC Dose escalation improves OS (GETUG-AFU 18) 🚨 Very high-risk / cN1 RT + ADT + abiraterone is the new benchmark STAMPEDE delivers MFS + OS benefit 🔁 Biochemical recurrence Avoid routine adjuvant RT Early salvage RT preferred RADICALS-RT | RAVES | GETUG-AFU 17 High-risk BCR? Intensify EMBARK supports enzalutamide + ADT 🧠 Bottom line Risk-adapted care > overtreatment Imaging-driven decisions Escalate only when trials prove benefit 📖 Full paper in comment ⬇️ #OncoTwitter #MedTwitter #ProstateCancer #GUOncology @OncoAlert @myesmo @esmo_open @asco @OncBrothers
2
74
1
185
27,822
Hyperbaric oxygen therapy for chronic radiotherapy‐related adverse effects: A clinically focused review pmc.ncbi.nlm.nih.gov/article…
29
68
5,351
📢 New SOC for MIBC #ESMO25 Dr. Christof Vulsteke presents KEYNOTE-905: 🚫 No cisplatin? No problem. EV+pembro delivers. 👥 n=344 cis-ineligible MIBC (80% renal impairment, 15% ECOG 2) 🔹 EFS HR 0.40 | OS HR 0.50 🔹 pCR: 57.1% vs 8.6% (ITT, non-op = non-responders) 🔹 No ↑ surgical complications ✅ 1st phase 3 trial showing OS benefit in this population| Unprecedented pCR↑ @urotoday @myESMO
2
34
5
92
18,165
Prof Amrith Rao retweeted
In a trial of men with suspected prostate cancer, biparametric MRI, which excludes the gadolinium contrast sequence, was noninferior to multiparametric MRI for detecting clinically significant cases. 🧵 ja.ma/4nhCVqy
4
29
4
43
18,941
Only ONE immigration officer for non EU passport holders at Schipol Airport, Amsterdam! Definitely they can do better! @Schiphol @Iamsterdam @Visit_NL @usambnl @DutchMFA @DutchNewsNL
1
2
217
Sad day for Urology! A silent giant indeed 🙏🏼
A very sad day learning that a giant in urology passed, Donald G. Skinner MD His impact was profound. His commitment to surgical excellence was only matched by his devotion to pt care and teaching. Simply the best mentor, colleague and friend RIP Boss @UroOnc @AmerUrological
178
Interesting thread!
I learned this week that SABR-COMET patient #1 recently passed away, more than 12 years after enrollment, with no recurrence since his original SABR. We initially treated him for a left adrenal met. It’s an interesting story… ⬇️⬇️⬇️
1
111
Replying to @airtelindia
@airtelindia @JM_Scindia @airtelnews @DoT_India @PMOIndia @narendramodi @AmitShah Airtel India has one of the worst customer services. I am a NRI and have been on intl roaming for 5 years & givin good business. But the service is horrendous!
4
1
148
@airtelindia @Airtel_Presence @SunilBhartiMitl @PMOIndia @JM_Scindia Dear Airtel Team - I was assured that someone would call me regarding the issue I am facing and no call has been recieved. Extremely poor service for NRIs like me who would want to keep in touch with India.
1
1
1
144
🧠⚡️ #radonc
1
25
92
6,776
Out now and open access 👇: Cardiovascular Risks and Survival with Abiraterone vs Enzalutamide in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer in Germany: AVENGER Study @Uroweb @OncoAlert @brunolarvol @urotoday @UKSH_KI_HL rdcu.be/ebWMr
1
12
24
3,214
Prof Amrith Rao retweeted
Great summary re: avoiding false positive PSMA pitfalls from Irene Burger #APCCCDiagnostics25
42
1
105
11,500
Very nice thread! 👍🏽
🚨 The 2024 FROGG Guidelines for Post-Prostatectomy Radiation Therapy (PPRT) are here, bringing groundbreaking updates backed the by the latest evidence❗️@OncoAlert 🧵1/7
1
147